Fresh from surgery, Raul Fernandez will try and return to action at this week’s final MotoGP pre-season test in Buriram. The Spaniard was among three riders to be injured on the very first day ...

For better or worse, head coach Jordi Fernandez has been impressive this season with such limited weapons in Brooklyn. The first-year head coach got the Nets off to a solid start, going 9-11 in ...

The Brooklyn Nets are now 18-34 after a 102-86 win against the Miami Heat, with head coach Jordi Fernández praising the team’s defense and ‘next man’ mentality for Friday night’s result.

During the joint presentation of all the MotoGP teams for the 2025 season held in Bangkok, Trackhouse Racing's Team Principle Davide Brivio confirmed that Raul Fernandez will try to take part in ...

Raúl Fernández has already been successfully operated on his left hand due to the fracture he suffered on the first day of MotoGP testing in Sepang. The rider may head to Buriram for the next tests.

Raúl Fernández was one of the notable absentees during the last two days of MotoGP testing at Sepang, but it seems that he is on the road to recovery and should even be at the next tests in Thailand.

Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy ...

Within the broader S&P 500, when components were ranked in terms of analyst favorites, AMGN claims the #342 spot. BNK Invest Inc. provides investment services and information. BNK Invest owns and ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other stocks that Jim Cramer discusses that are leading the Dow higher in 2025. On Thursday ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The company’s shares closed last Friday at $293.54.